Skip to content
MedsAcross

Brand family

Sylvant

Siltuximab · Recordati Rare Diseases
United States
Presentations
2
Markets
1

Sylvant is a brand of Siltuximab marketed by Recordati Rare Diseases, with 2 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Siltuximab
Brand owner
Recordati Rare Diseases
Registered in
United States
Strengths and forms
100 mg powder for injection, 400 mg powder for injection

All presentations

MedicineManufacturerRegisterAvailability
Sylvant 100 mg powder for injectionIntravenous Cold chainRecordati Rare DiseasesUS FDAAvailable on request
Sylvant 400 mg powder for injectionIntravenous Cold chainRecordati Rare DiseasesUS FDAAvailable on request

Brand names and trademarks belong to their owners and are used only to identify products.

Request Sylvant

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.